Symrise AG
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SYIEY research report →
Price Chart
About the company
Symrise AG is a German-based specialist in providing a comprehensive array of ingredients, encompassing fragrances, flavor compounds, active cosmetic components, and functional raw materials. Its operations are structured into two principal divisions: Taste, Nutrition & Health, and Scent & Care. The 'Taste, Nutrition & Health' division focuses on delivering flavor solutions and functional ingredients for the food and beverage industry, along with savory flavorings.
- CEO
- Jean-Yves Parisot
- IPO
- 2010
- Employees
- 12,745
- HQ
- Holzminden, NI, DE
Get TickerSpark's AI analysis on SYIEY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.11B
- P/E
- 35.50
- Fwd P/E
- 26.64
- PEG
- -1.32
- P/S
- 1.76
- P/B
- 3.51
- EV/EBITDA
- 11.84
- Div Yield
- 1.32%
- Gross Margin
- 37.57%
- Op Margin
- 11.02%
- Net Margin
- 5.01%
- ROE
- 9.90%
- ROIC
- 7.80%
Latest fiscal year · YoY change
- Revenue
- $4.76B-4.8%
- Gross Profit
- $1.81B-8.1%
- Op Income
- $585.25M
- Net Income
- $239.49M-49.9%
- EPS
- $0.43-50.3%
- OCF Growth
- -23.0%
- FCF Growth
- -23.2%
- 52W High
- $28.77
- 52W Low
- $19.31
- 50D MA
- $26.49
- 200D MA
- $24.12
- Beta
- 0.59
- RSI (14)
- 42
- Avg Volume
- 47.03K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Symrise said first-half growth improved into Q2, cash generation was a standout, and management reaffirmed full-year guidance while advancing its ONE SYM transformation.· July 30, 2026
- H1 sales were EUR 2.539 billion with 2% organic growth; Q2 organic growth accelerated to 4.5% after a softer Q1.
- Adjusted EBITDA was EUR 553 million with a 21.8% margin; gross profit was EUR 1.05 billion with a 41.3% gross margin.
- Adjusted business free cash flow rose 47% to EUR 347 million, or 13.7% of sales, and management still expects above 14% for the full year.
- North America and Asia Pacific led growth in Q2, while EAME and Latin America were softer on easier/harder comparables and weaker demand.
- Management reaffirmed 2026 guidance for 2% to 4% organic growth, 21.5% to 22.5% adjusted EBITDA margin, and above 14% cash flow margin.
First-half sales were EUR 2.539 billion, with 2% organic growth. Q2 sales were EUR 1.22 billion and organic sales rose 4.5%, driven by 5.1% volume growth and a 0.7% negative pricing effect. Adjusted EBITDA for H1 was EUR 553 million with a 21.8% margin, while gross profit was EUR 1.05 billion and gross margin was 41.3%, essentially in line with last year. Adjusted business free cash flow increased 47% year over year to EUR 347 million, or 13.7% of sales, up 450 basis points. Segment-wise, Taste, Nutrition & Health adjusted EBITDA was EUR 372 million with a 24.5% margin, and Scent & Care adjusted EBITDA was EUR 178 million with a 17.7% margin. Management reaffirmed full-year 2026 guidance for organic sales growth of 2% to 4%, adjusted EBITDA margin of 21.5% to 22.5%, and adjusted business free cash flow margin above 14%; it also said Q3 should see organic growth similar to Q2, around 4% to 5%.
Jean-Yves Parisot emphasized that the business gained momentum through the half, with stronger commercial execution, broad-based strength in North America and Asia Pacific, and a clear step-up in Q2 growth. He framed ONE Symrise and ONE SYM as moving from planning into implementation, with priorities now focused on productivity, simpler operations, and better resource allocation. His tone was constructive and confident, especially around the company’s ability to combine growth, profitability, and cash generation while reshaping the portfolio.
Olaf Klinger highlighted that profitability held up despite higher freight and logistics costs tied to the geopolitical situation in the Middle East, timing lags on customer surcharges, and continued investment behind growth. He cited gross profit of EUR 1.05 billion, gross margin of 41.3%, adjusted EBITDA of EUR 553 million, and extraordinary items of EUR 9.3 million related to M&A, legal expenses, and transformation costs. Cash generation was a key focus: adjusted business free cash flow reached EUR 347 million, net debt rose to EUR 2.3 billion from EUR 2.1 billion at year-end 2025, the equity ratio improved to 49.2%, net leverage was 2.2x adjusted EBITDA, and the buyback program had about EUR 192 million invested at H1 end.
Analysts pressed on whether the strong cash flow was structural or timing-related, and Olaf said the H1 result reflected disciplined working capital management, improved supplier payment terms, inventory discipline, and CapEx control, not a one-off tax effect. On Pet Nutrition, management said pricing pressure is still present but much less severe than last year, and that Q3/Q4 should be better on volumes as carryover deliveries and stronger demand in wet and dry pet food flow through. Questions also focused on Scent & Care pricing, where management said lower pricing is tactical and offset by volume growth and operational excellence, and on the Aroma portfolio, where management described portfolio optimization rather than a broad divestment program beyond Terpenes.
The call pointed to a stronger second quarter, with 4.5% organic growth, good volume momentum, and particularly strong performance in North America and Asia Pacific. Management sounded confident that cash conversion is improving structurally, that Q3 should resemble Q2, and that Pet, Scent & Care, and premium natural ingredients all have room to improve. The company also reiterated a clear path to its midterm 5% to 7% organic growth CAGR target by 2028.
Management acknowledged softer performance in EAME and Latin America, ongoing margin pressure from freight, logistics, and raw materials, and lower pricing in parts of Scent & Care and Pet Nutrition. Pet Nutrition still faces tactical price concessions, and management would not rule out further pricing trade-offs if needed to protect volume or share. The ONE SYM transformation is still early in implementation, and management said they are reinvesting efficiencies rather than immediately showing all savings in the P&L.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.8%
- Shares Outstanding
- 548.72M
- Float Shares
- 520.21M
of shares held by institutions
9 13F filers
Congressional trading
Senate and House stock disclosures for SYIEY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Josh GottheimerHouse · NJ05 | Sell | Jun 21, 24 | Filing → |
| Daniel GoldmanHouse · NY10 | Sell | Jul 10, 23 | Filing → |
| Daniel GoldmanHouse · NY10 | Buy | Mar 31, 23 | Filing → |
| Peter MeijerHouse · MI03 | Sell | Feb 17, 21 | Filing → |
| Greg GianforteHouse · MT00 | Buy | Aug 4, 20 | Filing → |
| Donna ShalalaHouse · FL27 | Sell | Jun 24, 19 | Filing → |
| Greg GianforteHouse · MT00 | Sell | Jan 13, 20 | Filing → |
| Greg GianforteHouse · MT00 | Sell | Jul 5, 18 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Aristotle Capital Management, LLC | 2.10M | ▼ 123.20K |
| Hantz Financial Services, Inc. | 43.22K | ▼ 6.27K |
| Rhumbline Advisers | 17.82K | ▲ 965 |
| Pnc Financial Services Group, Inc. | 4.35K | ▼ 199 |
| Ima Advisory Services, Inc. | 388 | ▲ 388 |
| First Command Advisory Services, Inc. | 152 | ▲ 81 |
| Ascentis Wealth Management, LLC | 88 | ▲ 88 |
Held by 8 ETFs
Biggest fund positions in SYIEY by dollar value.
Our SYIEY coverage
Recent articles, reports, and earnings notes.
No research on SYIEY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SYIEY report →Symrise taps Martin Huber as chief financial officer from April 2027
reuters.com · Nov 10
What Symrise (SY1) Said on Its Q3 Earnings Call
marketbeat.com · Oct 28
Symrise AG (SYIEY) Q3 2026 Earnings Call Transcript
seekingalpha.com · Oct 28
Symrise flags slower Q4 growth, spending pressure on margins
reuters.com · Oct 28
Symrise (OTCMKTS:SYIEY) Reaches New 1-Year High – Time to Buy?
defenseworld.net · Oct 21
Symrise AG Unsponsored ADR (OTCMKTS:SYIEY) Stock Rated “Moderate Buy” by Sell-Side Brokerages
defenseworld.net · Sep 25
Symrise (OTCMKTS:SYIEY) Shares Break Above Fifty Day Moving Average – Time to Sell?
defenseworld.net · Sep 25
Symrise AG (SYIEY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.